Simplex Trading’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $252K | Buy |
3,900
+2,100
| +117% | +$148K | ﹤0.01% | 4020 |
|
|
2025
Q4 | $121K | Sell |
1,800
-13,500
| -88% | -$908K | ﹤0.01% | 4788 |
|
|
2025
Q3 | $1.12M | Buy |
15,300
+200
| +1% | +$13.3K | ﹤0.01% | 2944 |
|
|
2025
Q2 | $785K | Buy |
15,100
+4,300
| +40% | +$245K | ﹤0.01% | 3036 |
|
|
2025
Q1 | $689K | Buy |
10,800
+400
| +4% | +$23.2K | ﹤0.01% | 3054 |
|
|
2024
Q4 | $497K | Sell |
10,400
-12,400
| -54% | -$636K | ﹤0.01% | 3545 |
|
|
2024
Q3 | $1.3M | Buy |
22,800
+22,300
| +4,460% | +$1.28M | ﹤0.01% | 2667 |
|
|
2024
Q2 | $26K | Sell |
500
-1,300
| -72% | -$57K | ﹤0.01% | 6678 |
|
|
2024
Q1 | $73K | Sell |
1,800
-9,100
| -83% | -$341K | ﹤0.01% | 5913 |
|
|
2023
Q4 | $402K | Sell |
10,900
-7,400
| -40% | -$279K | ﹤0.01% | 3929 |
|
|
2023
Q3 | $699K | Buy |
18,300
+11,400
| +165% | +$467K | ﹤0.01% | 3040 |
|
|
2023
Q2 | $248K | Buy |
6,900
+2,400
| +53% | +$81.9K | ﹤0.01% | 4058 |
|
|
2023
Q1 | $171K | Sell |
4,500
-59,100
| -93% | -$2.77M | ﹤0.01% | 4507 |
|
|
2022
Q4 | $3.62M | Buy |
63,600
+47,400
| +293% | +$2.43M | ﹤0.01% | 1430 |
|
|
2022
Q3 | $640K | Buy |
16,200
+12,800
| +376% | +$566K | ﹤0.01% | 3176 |
|
|
2022
Q2 | $149K | Buy |
3,400
+2,900
| +580% | +$125K | ﹤0.01% | 5011 |
|
|
2022
Q1 | $19K | Sell |
500
-8,000
| -94% | -$285K | ﹤0.01% | 8297 |
|
|
2021
Q4 | $341K | Sell |
8,500
-18,600
| -69% | -$694K | ﹤0.01% | 4367 |
|
|
2021
Q3 | $1.26M | Hold |
27,100
| – | – | ﹤0.01% | 2763 |
|
|
2021
Q2 | $1.23M | Buy |
+27,100
| New | +$1.2M | ﹤0.01% | 2818 |
|
|
2021
Q1 | – | Sell |
-71
| Closed | -$303K | – | 9268 |
|
|
2020
Q4 | $303K | Sell |
71
-98
| -58% | -$3.52K | ﹤0.01% | 4059 |
|
|
2020
Q3 | $444K | Sell |
169
-94
| -36% | -$2.62K | ﹤0.01% | 3145 |
|
|
2020
Q2 | $705K | Buy |
263
+108
| +70% | +$2.44K | ﹤0.01% | 2481 |
|
|
2020
Q1 | $278K | Buy |
155
+40
| +35% | +$759 | ﹤0.01% | 3220 |
|
|
2019
Q4 | $203K | Buy |
115
+64
| +125% | +$1.11K | ﹤0.01% | 3740 |
|
|
2019
Q3 | $79K | Buy |
51
+3
| +6% | +$49 | ﹤0.01% | 4563 |
|
|
2019
Q2 | $82K | Sell |
48
-47
| -49% | -$758 | ﹤0.01% | 4386 |
|
|
2019
Q1 | $152K | Buy |
95
+40
| +73% | +$648 | ﹤0.01% | 3900 |
|
|
2018
Q4 | $80K | Buy |
55
+41
| +293% | +$654 | ﹤0.01% | 4066 |
|
|
2018
Q3 | $25K | Sell |
14
-35
| -71% | -$613 | ﹤0.01% | 5779 |
|
|
2018
Q2 | $82K | Buy |
49
+31
| +172% | +$586 | ﹤0.01% | 4509 |
|
|
2018
Q1 | $2K | Sell |
18
-73
| -80% | -$1.41K | ﹤0.01% | 5265 |
|
|
2017
Q4 | $4K | Sell |
91
-54
| -37% | -$993 | ﹤0.01% | 4681 |
|
|
2017
Q3 | $9K | Sell |
145
-209
| -59% | -$2.83K | ﹤0.01% | 3863 |
|
|
2017
Q2 | $50K | Buy |
354
+112
| +46% | +$1.5K | ﹤0.01% | 2396 |
|
|
2017
Q1 | $54K | Sell |
242
-101
| -29% | -$1.28K | ﹤0.01% | 2279 |
|
|
2016
Q4 | $107K | Buy |
343
+209
| +156% | +$2.29K | 0.01% | 1477 |
|
|
2016
Q3 | $32K | Buy |
134
+16
| +14% | +$164 | ﹤0.01% | 2516 |
|
|
2016
Q2 | $47K | Sell |
118
-24
| -17% | -$237 | ﹤0.01% | 2119 |
|
|
2016
Q1 | $10K | Sell |
142
-85
| -37% | -$800 | ﹤0.01% | 3451 |
|
|
2015
Q4 | $27K | Buy |
227
+43
| +23% | +$685 | ﹤0.01% | 2442 |
|
|
2015
Q3 | $22K | Sell |
184
-98
| -35% | -$1.97K | ﹤0.01% | 2685 |
|
|
2015
Q2 | $7K | Buy |
282
+95
| +51% | +$1.67K | ﹤0.01% | 3366 |
|
|
2015
Q1 | $25K | Buy |
187
+20
| +12% | +$288 | ﹤0.01% | 2144 |
|
|
2014
Q4 | $22K | Buy |
+167
| New | +$1.48K | ﹤0.01% | 1969 |
|
Other funds holding HALO
VCM
VPM
Simplex Trading's HALO Position: Q3 2025 in Review
Simplex Trading sold out of Halozyme (HALO) in Q3 2025, closing a stake of 1,069 shares — an estimated $71K sold.
Simplex Trading first reported a position in HALO in Q1 2015 and held it in 20 quarters. The position peaked at $870K in Q3 2020. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.
- Simplex Trading reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 1,069 Halozyme shares in Q3 2025, an estimated $71K.
- Simplex Trading first reported a position in Halozyme in Q1 2015 and held it in 20 quarters.
- Simplex Trading's Halozyme position peaked at $870K in Q3 2020.
- 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.